Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

PAD Guidelines
New Guidelines Published to Lower the Risk of Amputation in Peripheral Artery Disease
05/14/2024

American Heart Association News

American Heart Association News ...
"It's important to recognize the signs and symptoms of PAD and move quickly to initiate treatment to improve outcomes and reduce risks," Dr. Heather Gornik, chair of the writing committee for the new guidelines, said. "With these updated...
"It's important to recognize the signs and symptoms of PAD and move quickly to initiate treatment to improve outcomes and reduce risks," Dr. Heather Gornik, chair of the writing committee for the new guidelines, said. "With these updated...
"It's important to recognize...
05/14/2024
Cath Lab Digest
structural heart procedures
Teleflex Announces Limited Market Release of the Wattson Temporary Pacing Guidewire
05/14/2024

Teleflex News

Teleflex News
Featuring a simple design to create procedural efficiencies, the Wattson™ Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during structural heart procedures, including...
Featuring a simple design to create procedural efficiencies, the Wattson™ Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during structural heart procedures, including...
Featuring a simple design to...
05/14/2024
Cath Lab Digest
TAVR
EuroPCR: Medtronic Evolut TAVR Platform Demonstrates Improved Quality of Life for Women with Severe Aortic Stenosis
05/14/2024
"This study is a major milestone for women, who have historically been excluded and underrepresented in clinical trials," said Roxana Mehran, MD.. "This subset of the data reinforces that compared to balloon-expandable valves, the Evolut TAVR...
"This study is a major milestone for women, who have historically been excluded and underrepresented in clinical trials," said Roxana Mehran, MD.. "This subset of the data reinforces that compared to balloon-expandable valves, the Evolut TAVR...
"This study is a major milestone...
05/14/2024
Cath Lab Digest

Advertisement

Quantitative Flow Ratio (QFR)
GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of CAD
05/14/2024

GE HealthCare and Medis Medical Imaging News

GE HealthCare and Medis Medical Imagi...
Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional...
Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional...
Together, the two companies will...
05/14/2024
Cath Lab Digest
Obstructive HCM
SEQUOIA-HCM Trial: Experimental Drug Aficamten Makes Exercise, Everyday Tasks Easier for People With Obstructive Hypertrophic Cardiomyopathy
05/14/2024

Oregon Health & Science University and European Society of Cardiology News

Oregon Health & Science Universit...
This study demonstrated that aficamten enhanced HCM patients’ exercise capacity with significant improvement in peak oxygen uptake (pVO2), improvement in limiting symptoms, and decreases in LVOT pressure gradients.
This study demonstrated that aficamten enhanced HCM patients’ exercise capacity with significant improvement in peak oxygen uptake (pVO2), improvement in limiting symptoms, and decreases in LVOT pressure gradients.
This study demonstrated that...
05/14/2024
Cath Lab Digest
MI Therapies
Researchers Find Beneficial Effects of Novel Drug Sacubitril/Valsartan in Management of Myocardial Infarction
05/14/2024

Germans Trias i Pujol Research Institute News

Germans Trias i Pujol Research Instit...
Sacubitril/Valsartan is a combination drug that has achieved promising results in reducing the rehospitalisation rates and cardiovascular deaths in patients with heart failure. The present work aimed to evaluate the effects of early...
Sacubitril/Valsartan is a combination drug that has achieved promising results in reducing the rehospitalisation rates and cardiovascular deaths in patients with heart failure. The present work aimed to evaluate the effects of early...
Sacubitril/Valsartan is a...
05/14/2024
Cath Lab Digest

Advertisement

Heart Failure
Impulse Dynamics Surpasses 10,000 Patients Benefiting From Cardiac Contractility Modulation (CCM) Therapy for Heart Failure
05/13/2024

Impulse Dynamics News

Impulse Dynamics News
CCM is the brand name for cardiac contractility modulation—the non-excitatory electrical pulses delivered by the implantable Optimizer device to improve heart contraction. CCM therapy sends unique electrical pulses to the heart cells during...
CCM is the brand name for cardiac contractility modulation—the non-excitatory electrical pulses delivered by the implantable Optimizer device to improve heart contraction. CCM therapy sends unique electrical pulses to the heart cells during...
CCM is the brand name for...
05/13/2024
Cath Lab Digest
Genetics
Researchers Show Genetic Variant Common Among Black Americans Contributes to Large Cardiovascular Disease Burden
05/13/2024

Brigham and Women's Hospital and Duke University News

Brigham and Women's Hospital and Duke...
A genetic variant carried by 3-4 percent of self-identified Black Americans increases the risk for heart failure and death, contributing to a significant decrease in longevity at the population level, according to a new study led by...
A genetic variant carried by 3-4 percent of self-identified Black Americans increases the risk for heart failure and death, contributing to a significant decrease in longevity at the population level, according to a new study led by...
A genetic variant carried by 3-4...
05/13/2024
Cath Lab Digest
Resorbable Scaffolds
New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT)
05/13/2024

Biotronik News

Biotronik News
"We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the...
"We are delighted to enroll the first patient in the BIOMAG-II trial, which may play a critical role in helping establish resorbable metallic scaffolds as part of clinical practice in the future and I am particularly encouraged by the...
"We are delighted to enroll the...
05/13/2024
Cath Lab Digest

Advertisement

Hypertrophic Cardiomyopathy
American College of Cardiology, American Heart Association Issue New Guideline for Evaluation and Management of People With HCM
05/08/2024

American College of Cardiology and American Heart Association News

American College of Cardiology and Am...
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
The guideline reiterates the...
05/08/2024
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use